Biocon Ltd. is a prominent biopharmaceutical company based in India, specializing in the development and production of innovative and cost-effective medical therapies. The company's primary focus lies in biopharmaceuticals, including biologics, biosimilars, complex active pharmaceutical ingredients (APIs), and branded formulations. Serving various sectors, Biocon operates in oncology, diabetes, and autoimmune diseases, where it delivers health solutions through its research-driven approach and state-of-the-art manufacturing facilities. As an integral player in the global pharmaceuticals market, Biocon emphasizes leveraging its robust R&D capabilities to drive product innovation and affordability across multiple healthcare systems worldwide. The company's strategic collaborations and partnerships reinforce its role in advancing accessible healthcare, contributing significantly to the biopharmaceutical industry's growth and evolution. Founded in 1978, Biocon Ltd. has expanded its footprint beyond the Indian market, establishing a significant international presence and playing a crucial role in enhancing global healthcare outcomes.